Modifiable Risk Factors and Residual Risk Following Coronary Revascularization
-
Published:2021-12
Issue:6
Volume:5
Page:1138-1152
-
ISSN:2542-4548
-
Container-title:Mayo Clinic Proceedings: Innovations, Quality & Outcomes
-
language:en
-
Short-container-title:Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Author:
Simard TrevorORCID, Jung Richard G., Di Santo Pietro, Harnett David T.ORCID, Abdel-Razek Omar, Ramirez F. DanielORCID, Motazedian Pouya, Parlow Simon, Labinaz Alisha, Moreland RobertORCID, Marbach Jeffrey, Poulin Anthony, Levi Amos, Majeed Kamran, Boland PaulORCID, Couture Etienne, Sarathy Kiran, Promislow Steven, Russo Juan J., Chong Aun Yeong, So Derek, Froeschl Michael, Dick Alexander, Labinaz Marino, Le May Michel, Holmes David R.ORCID, Hibbert BenjaminORCID
Reference56 articles.
1. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study;Yusuf;Lancet,2004 2. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017;Roth;Lancet,2018 3. Leading causes of death, total population, by age group;Statistics Canada,2020 4. Bivalirudin for primary percutaneous coronary interventions: outcome assessment in the Ottawa STEMI registry;Hibbert;Circ Cardiovasc Interv,2012 5. A randomised study for optimising crossover from ticagrelor to clopidogrel in patients with acute coronary syndrome: the CAPITAL OPTI-CROSS Study;Pourdjabbar;Thromb Haemost,2017
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|